摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-氨基-5-三氟甲基苯甲酰胺 | 16499-54-0

中文名称
2-氨基-5-三氟甲基苯甲酰胺
中文别名
——
英文名称
2-amino-5-(trifluoromethyl)benzamide
英文别名
——
2-氨基-5-三氟甲基苯甲酰胺化学式
CAS
16499-54-0
化学式
C8H7F3N2O
mdl
——
分子量
204.152
InChiKey
MOKMVZDIJPORMZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    258.3±40.0 °C(Predicted)
  • 密度:
    1.418±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.6
  • 重原子数:
    14
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.12
  • 拓扑面积:
    69.1
  • 氢给体数:
    2
  • 氢受体数:
    5

安全信息

  • 海关编码:
    2924299090

SDS

SDS:f5d91c47f9a7907ba4ed13d23d4740c7
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 2-Amino-5-(trifluoromethyl)benzamide
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 2-Amino-5-(trifluoromethyl)benzamide
CAS number: 16499-54-0

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C8H7F3N2O
Molecular weight: 204.1

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen fluoride.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-氨基-5-三氟甲基苯甲酰胺盐酸potassium carbonate 、 sodium nitrite 作用下, 以 N,N-二甲基甲酰胺丙酮 为溶剂, 反应 1.92h, 生成
    参考文献:
    名称:
    1,2,3-Benzotriazin-4-one衍生物对根结线虫的合成及杀线虫活性
    摘要:
    通过3-溴烷基-1,2,3-苯并三嗪-4-酮与2-氰基氨基-4-氧噻唑烷的钾盐反应,合成了一系列新的1,2,3-苯并三嗪-4-酮衍生物。碘化钾的存在。杀线虫试验在体内表明,它们中的一些表现出对所造成的黄瓜根结线虫病良好的防治效果南方根结线虫以10.0毫克的L的浓度,最高可达100%-1,表明1,2,3-苯并三-4-one衍生物可能是新型杀线虫剂的潜力。杀线虫活性受分子中取代基类型,取代位置和接头长度的组合影响。浓度为5.0和1.0 mg L –1时的抑制率数据还提供了具有高抑制活性的化合物。当在体外测试时,没有一个对隐孢霉菌有直接抑制作用。体内和体外数据之间显着差异的研究正在进行中。
    DOI:
    10.1021/acs.jafc.5b01762
  • 作为产物:
    描述:
    2-硝基-5-(三氟甲基)苯甲腈 在 palladium on activated charcoal 硫酸氢气 作用下, 生成 2-氨基-5-三氟甲基苯甲酰胺
    参考文献:
    名称:
    喹唑啉。第九部分 取代的喹唑啉类中性物质中的共价水合
    摘要:
    发现二十八种喹唑啉的水合物与无水中性物质的比率在10 –2 –10 –5的范围内。取代基对该比例的影响在中性物质中表现出与在相应阳离子中观察到的相当,并且表明影响这两种物质中水合量的因素相似。测量了三十二个喹唑啉的水合物种的电离常数,并讨论了取代基对这些常数的影响。
    DOI:
    10.1039/j29670000449
点击查看最新优质反应信息

文献信息

  • Copper-Catalyzed One-Pot Synthesis of Quinazolinones from 2-Nitrobenzaldehydes with Aldehydes: Application toward the Synthesis of Natural Products
    作者:Subrata Sahoo、Shantanu Pal
    DOI:10.1021/acs.joc.1c02343
    日期:2021.12.17
    A novel, efficient, and atom-economical approach for the construction of quinazolinones from 2-nitrobenzaldehydes has been unveiled via copper-catalyzed nitrile formation, hydrolysis, and reduction in one pot for the first time. In this reaction, urea is used as a source of nitrogen for nitrile formation, hydrazine hydrate is used for both the reduction of the nitro group and the hydrolysis of nitrile
    首次通过铜催化的腈形成、水解和还原在一个锅中揭示了一种从 2-硝基苯甲醛构建喹唑啉酮的新型、高效和原子经济的方法。在该反应中,尿素用作生成腈的氮源,水合肼用于硝基的还原和腈的水解,大气中的氧气用作唯一的氧化剂。该方法描绘了具有良好官能团耐受性的宽底物范围。此外,该方法还用于合成裂殖菌素、色胺菊酯、phaitanthrin-A、phaitanthrin-B和8 H-喹唑啉[4,3 - b ]quinazolin-8-one。
  • SUBSTITUTED 2- AMIDOQUINAZOL-4-ONES AS MATRIX METALLOPROTEINASE-13 INHIBITORS
    申请人:Takeda Pharmaceutical Company Limited
    公开号:US20150329556A1
    公开(公告)日:2015-11-19
    The present invention provides a novel amide derivative having a matrix metalloproteinase inhibitory activity, and useful as a pharmaceutical agent, which is a compound represented by the formula (I) wherein ring A is an optionally substituted, nitrogen containing heterocycle, ring B is an optionally substituted monocyclic homocycle or an optionally substituted monocyclic heterocycle, Z is N or NR 1 (R 1 is a hydrogen atom or an optionally substituted hydrocarbon group), is a single bond or a double bond, R 2 is a hydrogen atom or an optionally substituted hydrocarbon group, X is an optionally substituted spacer having 1 to 6 atoms, ring C is (1) an optionally substituted homocycle or (2) an optionally substituted heterocycle other than a ring represented by (II) (X′ is S, O, SO, or CH 2 ), and at least one of ring B and ring C has substituent(s), provided that N-(1S,2R)-1-(3,5-difluorobenzyl)-3-[(3-ethylbenzyl)amino]2 hydroxypropyl}5,6 dimethyl 4 oxo 1,4 dihydrothieno[2,3-d]pyrimidine-2-carboxamide is excluded, or a salt thereof.
    本发明提供了一种新型酰胺衍生物,具有基质金属蛋白酶抑制活性,并且作为药用剂是有用的,该化合物由以下式(I)表示,其中环A是一个可选择取代的含氮杂环,环B是一个可选择取代的单环同核环或可选择取代的单环杂环,Z是N或NR1(R1是氢原子或可选择取代的碳氢基团),是一个单键或双键,R2是氢原子或可选择取代的碳氢基团,X是一个具有1到6个原子的可选择取代的间隔物,环C是(1)一个可选择取代的同核环或(2)一个除了由(II)表示的环之外的可选择取代的杂环(X′是S、O、SO或CH2),并且环B和环C中至少有一个有取代基,但不包括N-(1S,2R)-1-(3,5-二氟苄基)-3-[(3-乙基苄基)氨基]2-羟基丙基}5,6-二甲基-4-氧代-1,4-二氢噻唑并[2,3-d]嘧啶-2-羧酰胺,或其盐。
  • Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity
    申请人:Carter H. Percy
    公开号:US20050054626A1
    公开(公告)日:2005-03-10
    The present application describes modulators of MCP-1 of formula (I): or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma, multiple sclerosis, artherosclerosis, and rheumatoid arthritis.
    本申请描述了MCP-1的调节剂,化学式为(I):或其药用可接受的盐形式,用于预防哮喘、多发性硬化症、动脉粥样硬化和类风湿性关节炎。
  • [EN] HETEROCYCLIC AMIDE COMPOUND AND USE THEREOF AS AN MMP-13 INHIBITOR<br/>[FR] COMPOSÉ AMIDE HETEROCYCLIQUE ET UTILISATION DE CELUI-CI EN TANT QU'INHIBITEUR MMP-13
    申请人:TAKEDA PHARMACEUTICAL
    公开号:WO2005105760A1
    公开(公告)日:2005-11-10
    The present invention provides a novel amide derivative having a matrix metalloproteinase inhibitory activity, and useful as a pharmaceutical agent, which is a compound represented by the formula (I) wherein ring A is an optionally substituted, nitrogen-containing heterocycle, ring B is an optionally substituted monocyclic homocycle or an optionally substituted monocyclic heterocycle, Z is N or NR1 (R1 is a hydrogen atom or an optionally substituted hydrocarbon group), - - - is a single bond or a double bond, R2 is a hydrogen atom or an optionally substituted hydrocarbon group, X is an optionally substituted spacer having 1 to 6 atoms, ring C is (1) an optionnally substituted homocycle or (2) an optionally substituted heterocycle other than a ring represented by (II) (X’ is S, O, SO, or CH2), and at least one of ring B and ring C has substituent(s), provided that N-(1S,2R)-1-(3,5-difluorobenzyl)-3-[(3-ethylbenzyl)amino]-2-hydroxypropyl}-5,6-dimethyl-4-oxo-1,4-dihadrothieno[2,3-d]pyrimidine-2-carboxamide is excluded, or a salt thereof.
    本发明提供了一种新型酰胺衍生物,具有基质金属蛋白酶抑制活性,并且作为药用剂是有用的,该化合物由以下式(I)表示,其中环A是一个可选择取代的含氮杂环,环B是一个可选择取代的单环同核环或可选择取代的单环杂环,Z是N或NR1(R1是氢原子或可选择取代的碳氢基团),- - - 是一个单键或双键,R2是氢原子或可选择取代的碳氢基团,X是具有1到6个原子的可选择取代的间隔物,环C是(1)一个可选择取代的同核环或(2)除了由(II)表示的环之外的可选择取代的杂环(X'是S、O、SO或CH2),并且环B和环C中至少有一个具有取代基,但不包括N-(1S,2R)-1-(3,5-二氟苄基)-3-[(3-乙基苄基)氨基]-2-羟基丙基}-5,6-二甲基-4-氧代-1,4-二氢噻吩[2,3-d]嘧啶-2-羧酰胺或其盐。
  • Novel Fluorene Derivatives, Composition Containing Said Derivatives and the Use Thereof
    申请人:MAILLIET Patrick
    公开号:US20080153837A1
    公开(公告)日:2008-06-26
    This invention relates to derivatives of 4-(benzimidazol-2-yl)fluorene and 4-(azabenzimidazol-2-yl)fluorene, to pharmaceutical compositions comprising such derivatives, and to methods of treatment of disorders related to Hsp90 protein activity, comprising administering such derivatives.
    这项发明涉及4-(苯并咪唑-2-基)芴和4-(氮杂苯并咪唑-2-基)芴的衍生物,涉及包含这些衍生物的药物组合物,以及涉及治疗与Hsp90蛋白活性相关的疾病的方法,包括给予这些衍生物。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐